DI Wu

DI Wu

Auto-generated profile, based on publicly available information

DI Wu

School of Medicine Nankai University Tianjin China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
DWDi Wu
Di Wu
ZYZhifeng Yan
Zhifeng Yan
MLMingxia Li
Mingxia Li
MWMingyang Wang
Mingyang Wang
YMYuanguang Meng
Yuanguang Meng
Endometrial cancer (EC) incidence and the associated tumour burden have increased globally. To build a molecular expression prognostic model based on the tumour microenvironment to guide personalised treatment using a machine learning approach. Two datasets were reviewed, including a training cohort (n = 698) and a testing cohort (n = 151). All patients underwent hysterectomy ± adnexectomy ± lymph nodes dissection between December 2014 and June 2020 at the PLA General Hospital First Medical Center and received necessary and regular follow‐up. We developed novel models using R software to predict factors that affect survival, such as progression‐free survival and overall survival. Then, the model was optimised by evaluating the prediction efficiency in multiple dimensions. Eight hundred and forty‐nine patients with EC were included in the study. Survival‐related influences on EC patients were identified by univariate analysis and cox regression equations. In addition, a nomogram was visualised in conjunction with demographic characteristics and the above meaningful clinicopathological variables. Ultimately, through a comprehensive assessment, a random forest model (RF16) was developed for complementing the findings of the molecular classification of EC. The RF16 not only specifically characterises tumour molecules, but also enhances the generalizability of the model by replacing gene sequencing with immunohistochemistry. This study showed that the machine learning model (RF16) is low‐cost, efficient, and clinically valuable in guiding treatment for EC patients.

11 June 2019 in Phytotaxa
Verified
Journal Article
Closed access
PDF file
XLXianyuan Li
Xianyuan Li
HPHui Peng
Hui Peng
XHXi He
Xi He
ZLZhineng Li
Zhineng Li
DWDI Wu
DI Wu
Guihaia heterosquama X. Y. Li, a new species from Chongqing, China, is described and illustrated. Guihaia heterosquama is similar to G. grossifibrosa and G. argyrata both in the shape of the leaf blade and flower structure, but it can be easily distinguished by its leaf scales, leaf sheath fibers and hastula. Notably, Guihaia heterosquama differs from all the reported species of Guihaia by the presence of a distinct pistillode in the male flower.